Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Belgium?, 2019-04-05 08:51 (564 d 01:42 ago) – Posting: # 20126
Views: 2,072

Hello to you too, PKS,

» Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

What does your protocol say on exactly that matter?

I could be wrong, but...

Best regards,

R's base package has 274 reserved words and operators, along with 1761 functions. I can use 18 of them (about 14 of them properly). I believe this makes me the Donald Trump of programming.

Complete thread:

 Admin contact
21,165 posts in 4,410 threads, 1,476 registered users;
online 7 (1 registered, 6 guests [including 4 identified bots]).
Forum time: Tuesday 10:34 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz